The concordance of treatment decision guided by OncotypeDX and the PREDICT tool in real‐world early‐stage breast cancer

BACKGROUND: Decision‐making regarding adjuvant chemotherapy for early‐stage breast cancer can be guided by genomic assays such as OncotypeDX. The concordance of expected clinical decisions guided by OncotypeDX and prognostication online tools such as PREDICT is unknown. METHODS: We performed a retro...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer Med
Hlavní autoři: Goldstein, Daniel A., Mayer, Chen, Shochat, Tzippy, Reinhorn, Daniel, Moore, Assaf, Sarfaty, Michal, Yerushalmi, Rinat, Goldvaser, Hadar
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2020
Témata:
Clinical Cancer Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7333833/
https://ncbi.nlm.nih.gov/pubmed/32372569
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3088
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky